|
[1] COOKE GS, ANDRIEUX-MEYER I, APPLEGATE TL, et al.Accelerating the elimination of viral hepatitis:A Lancet Gastroenterology&Hepatology Commission[J]. Lancet Gastroenterol Hepatol, 2019, 4(2):135-184.
|
|
[2] Chinese Society of Infectious Disease, Chinese Society of Hepatology, Chinese Medical Association. The expert consensus on functional cure of chronic hepatitis B[J]. J Clin Hepatol, 2019, 35(8):1693-1701.(in Chinese）中华医学会感染病学分会，中华医学会肝病学分会．慢性乙型肝炎临床治愈（功能性治愈）专家共识[J]．临床肝胆病杂志，2019, 35(8):1693-1701.
|
|
[3] Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol, 2019,35(12):2648-2669.(in Chinese）中华医学会感染病学分会，中华医学会肝病学分会．慢性乙型肝炎防治指南（2019年版）[J]．临床肝胆病杂志，2019, 35(12):2648-2669.
|
|
[4] XIA Y, LIANG TJ. Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection[J]. Gastroenterology, 2019, 156(2):311-324.
|
|
[5] SAEIDI A, ZANDI K, CHEOK YY, et al. T-cell exhaustion in chronic infections:Reversing the state of exhaustion and reinvigorating optimal protective immune responses[J]. Front Immunol, 2018, 9:2569.
|
|
[6] BURTON AR, PALLETT LJ, MCCOY LE, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B[J]. J Clin Invest, 2018, 128(10):4588-4603.
|
|
[7] SALIMZADEH L, LE BERT N, DUTERTRE CA, et al. PD-1blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection[J]. J Clin Invest, 2018,128(10):4573-4587.
|
|
[8] MAINI MK, BONI C, LEE CK, et al. The role of virus-specific CD8(+)cells in liver damage and viral control during persistent hepatitis B virus infection[J]. J Exp Med, 2000, 191(8):1269-1280.
|
|
[9] PARK JJ, WONG DK, WAHED AS, et al. Hepatitis B virusspecific and global T-cell dysfunction in chronic hepatitis B[J]. Gastroenterology, 2016, 150(3):684-695.
|
|
[10] TAN A, KOH S, BERTOLETTI A. Immune response in hepatitis B virus infection[J]. Cold Spring Harb Perspect Med, 2015,5(8):a021428.
|
|
[11] SCHUCH A, SALIMI ALIZEI E, HEIM K, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+T cells in chronically HBV-infected patients with low viral load[J]. Gut, 2019, 68(5):905-915.
|
|
[12] HOOGEVEEN RC, ROBIDOUX MP, SCHWARZ T, et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection[J].Gut, 2019, 68(5):893-904.
|
|
[13] SCHURICH A, PALLETT LJ, LUBOWIECKI M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells[J]. PLoS Pathog, 2013,9(3):e1003208.
|
|
[14] TANG L, CHEN C, GAO X, et al. Interleukin 21 reinvigorates the antiviral activity of hepatitis B virus(HBV)-specific CD8+T cells in chronic HBV infection[J]. J Infect Dis, 2019, 219(5):750-759.
|
|
[15] RINKER F, ZIMMER CL, HÖNER ZU SIEDERDISSEN C, et al.Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B[J]. J Hepatol, 2018, 69(3):584-593.
|
|
[16] RIVINO L, LE BERT N, GILL US, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation[J]. J Clin Invest, 2018, 128(2):668-681.
|
|
[17] SCHURICH A, PALLETT LJ, JAJBHAY D, et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host[J]. Cell Rep, 2016, 16(5):1243-1252.
|
|
[18] ZHANG S, ZHAO J, ZHANG Z. Humoral immunity, the underestimated player in hepatitis B[J]. Cell Mol Immunol, 2018,15(6):645-648.
|
|
[19] NEUMANN-HAEFELIN C, THIMME R. Entering the spotlight:Hepatitis B surface antigen-specific B cells[J]. J Clin Invest, 2018, 128(10):4257-4259.
|
|
[20] LE BERT N, SALIMZADEH L, GILL US, et al. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B[J]. J Hepatol, 2020, 72(1):34-44.
|
|
[21] CHEN Z, DIAZ G, POLLICINO T, et al. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure[J]. Proc Natl Acad Sci U S A, 2018, 115(48):e11369-e11378.
|
DownLoad: